4//SEC Filing
Giesing Dennis H 4
Accession 0001104659-22-073101
CIK 0001472012other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:05 PM ET
Size
5.6 KB
Accession
0001104659-22-073101
Insider Transaction Report
Form 4
Immunome Inc.IMNM
Giesing Dennis H
Chief Development Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-06-16+60,000→ 60,000 totalExercise: $3.42Exp: 2032-06-16→ Common Stock (60,000 underlying)
Footnotes (1)
- [F1]With respect to the options to purchase 30,000 shares, 25% of the shares subject to such options vest on June 16, 2023, and one-thirty-sixth (1/36th) of the remaining shares subject to such options shall vest every month thereafter. With respect to the remaining options to purchase 30,000 shares, 50% of the shares subject to such options vest on June 16, 2023, and the remaining 50% of the shares subject to such options vest on June 16, 2024.
Documents
Issuer
Immunome Inc.
CIK 0001472012
Entity typeother
Related Parties
1- filerCIK 0001853622
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 6:05 PM ET
- Size
- 5.6 KB